The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
Open accessAbstract
The cell surface hyaluronan receptor CD44 promotes tumor growth and metastasis by mechanisms that remain poorly understood. We show here that CD44 associates with a proteolytic form of the matrix metalloproteinase-9 (MMP-9) on the surface of mouse mammary carcinoma and human melanoma cells. CD44-associated cell surface MMP-9 promotes cell-mediated collagen IV degradation in vitro and mediates tumor cell invasion of G8 myoblast monolayers. Several distinct CD44 isoforms coprecipitate with MMP-9 and CD44/MMP-9 coclustering is observed to be dependent on the ability of CD44 to form hyaluronan-induced aggregates. Disruption of CD44/MMP-9 cluster formation, by overexpression of soluble or truncated cell surface CD44, is shown to inhibit tumor invasiveness in vivo. Our observations indicate that CD44 serves to anchor MMP-9 on the cell surface and define a mechanism for CD44-mediated tumor invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Self-citationTjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
Stetler-Stevenson, W. G., Aznavoorian, S., & Liotta, L. A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.002545 · Cited by 1,526
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
Pan, G., Ni, J., Wei, Y.-F., Yu, G.-L., Gentz, R., & Dixit, V. M. (1997) · Science · doi:10.1126/science.277.5327.815 · Cited by 1,496
Biology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Proteolytic remodeling of extracellular matrix
Birkedal-Hansen, H. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80116-2 · Cited by 1,074
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ
Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U., & Shaw, S. (1993) · Nature · doi:10.1038/361079a0 · Cited by 873
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Self-citationLymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen, S., & Jalkanen, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.3.817 · Cited by 530
Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., & Werb, Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35860-x · Cited by 525
Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., & Aruffo, A. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.687 · Cited by 427
Self-citationIdentification of hyaluronic acid binding sites in the extracellular domain of CD44
Peach, R., Hollenbaugh, D., Stamenkovic, I., & Aruffo, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.257 · Cited by 378
Self-citationStructural biochemistry and activation of matrix metalloproteases
Kleiner, D. E., & Stetler-Stevenson, W. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90040-w · Cited by 342
Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.6.1723 · Cited by 338
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
Self-citationBasbaum, C. B., & Werb, Z. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80116-5 · Cited by 323
CD44H regulates tumor cell migration on hyaluronate-coated substrate.
Thomas, L., Byers, H. R., Vink, J., & Stamenkovic, I. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.4.971 · Cited by 319
Self-citationOkada, Y., Naka, K., Kawamura, K., Matsumoto, T., Nakanishi, I., Fujimoto, N., Sato, H., & Seiki, M. (1995) · PubMed · Cited by 303
Distinct effects of two CD44 isoforms on tumor growth in vivo.
Sy, M. S., Guo, Y. J., & Stamenkovic, I. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.859 · Cited by 298
Self-citationType IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
Schnaper, H. W., Grant, D. S., Stetler‐Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560204 · Cited by 289
Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P., & Stamenkovic, I. (1997) · Genes & Development · doi:10.1101/gad.11.8.996 · Cited by 274
Self-citationYu, Q., Toole, B. P., & Stamenkovic, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1985 · Cited by 250
Self-citationScreaton, G. R., Bell, M. V., Bell, J. I., & Jackson, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31376-0 · Cited by 243
Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., Goldfarb, R. H., Khoury, G., & Liotta, L. A. (1987) · PubMed · Cited by 227
Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 201
Southern, J. A., Young, D. F., Heaney, F., Baumgartner, W. K., & Randall, R. E. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-7-1551 · Cited by 200
Sherman, L., Wainwright, D., Ponta, H., & Herrlich, P. (1998) · Genes & Development · doi:10.1101/gad.12.7.1058 · Cited by 169
Gelatinase B: Structure, Regulation, and Function
Vu, T. H., & Werb, Z. (1998) · Matrix Metalloproteinases · doi:10.1016/b978-012545090-4/50006-9 · Cited by 168
Culty, M., Shizari, M., Thompson, E. W., & Underhill, C. B. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600209 · Cited by 161
Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Sleeman, J. P., Rudy, W., Hofmann‐Apitius, M., Moll, J., Herrlich, P. A., & Ponta, H. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.1139 · Cited by 157
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F. A., & Aruffo, A. A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1623 · Cited by 155
Self-citationFas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.
Clement, M., & Stamenkovic, I. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.2.557 · Cited by 153
Self-citationLymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.
Jalkanen, S., Joensuu, H., Söderström, K. ‐., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115205 · Cited by 132
Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
Zheng, Z., Katoh, S., He, Q., Oritani, K., Miyake, K., Lesley, J., Hyman, R., Hamik, A., Parkhouse, R. M. E., & Farr, A. G. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.2.485 · Cited by 129
Sudbeck, B. D., Pilcher, B. K., Welgus, H. G., & Parks, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22103 · Cited by 113
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
Stetler‐Stevenson, W. G. (1993) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.9.1.541 · Cited by 97
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman, J. P., Arming, S., Moll, J. F., Hekele, A., Rudy, W., Sherman, L. S., Kreil, G., Ponta, H., & Herrlich, P. (1996) · PubMed · Cited by 87
Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic Acids
Odake, S., Morita, Y., Morikawa, T., Yoshida, N., Hori, H., & Nagai, Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1392 · Cited by 71
Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissues.
Yu, Q., & Toole, B. P. (1995) · PubMed · Cited by 44
Self-citationPotent peptide inhibitors of stromelysin based on the prodomain region of matrix metalloproteinases.
Fotouhi, N., Lugo, A., Visnick, M., Lusch, L., Walsky, R. L., Coffey, J. W., & Hanglow, A. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43801-x · Cited by 35
Cited by
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Self-citationThe biology and role of CD44 in cancer progression: Therapeutic implications
Chen, C., Zhao, S., Karnad, A., & Freeman, J. W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0605-5 · Cited by 1,245
Metadata
- Authors
- Yu, Q., & Stamenkovic, I.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-01-01
- Volume
- 13
- Issue
- 1
- Pages
- 35-48
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2112327424
- Cited by
- 713
- References
- 51
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.